Citrus Flavanones Blood Pressure Meta-Analysis Evidence Table

Structured evidence table for Citrus Flavanones Blood Pressure Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Citrus Flavanones Blood Pressure Meta-AnalysisGenetic factors, dietary habits, and lifestyle may influence individual responses to supplementation, including the bergamot flavanones naringin and naringenin, which are implicated in lipid modulation.2Yu X (2026)Lipid Metabolism Modulation by a Flavonoid-Standardized <i>Citrus Bergamia</i> Extract in an Asian Population: Findings From a Double-Blind, Placebo-Controlled Clinical Trial.
Citrus Flavanones Blood Pressure Meta-AnalysisThe aim of this double-blind, placebo-controlled clinical trial (RCT) is to assess the effects of the supplementation for four months of a standardised bergamot extract at the dosage of 375 mg/day, providing 150 mg/day of flavonoids, on lipid parameters of 108 East Asian adults with LDL-Cholesterol (LDL-C) 100-159 mg/day, since to date, the RCTs have been conducted on Caucasian subjects only.2Yu X (2026)Lipid Metabolism Modulation by a Flavonoid-Standardized <i>Citrus Bergamia</i> Extract in an Asian Population: Findings From a Double-Blind, Placebo-Controlled Clinical Trial.
Citrus Flavanones Blood Pressure Meta-AnalysisFlavanones, a subclass of flavonoids predominantly found in citrus fruits, have attracted growing interest for their potential role in cardiometabolic health.3Doaei S (2026)Flavanone Intake and Cardiometabolic Outcomes: A Synthesis of Meta-Analytic Evidence from Cohort and Clinical Studies.
Citrus Flavanones Blood Pressure Meta-AnalysisWhile evidence linking overall flavonoid intake to cardiometabolic benefits is relatively consistent, flavanones have received less attention, and available findings remain scattered across heterogeneous outcomes and study designs.3Doaei S (2026)Flavanone Intake and Cardiometabolic Outcomes: A Synthesis of Meta-Analytic Evidence from Cohort and Clinical Studies.
Citrus Flavanones Blood Pressure Meta-AnalysisThis review synthesizes meta-analytic evidence from prospective cohort and intervention studies to provide a comprehensive assessment of the relationship between flavanone intake and cardiometabolic health.3Doaei S (2026)Flavanone Intake and Cardiometabolic Outcomes: A Synthesis of Meta-Analytic Evidence from Cohort and Clinical Studies.
topicCitrus Flavanones Blood Pressure Meta-Analysis
claimGenetic factors, dietary habits, and lifestyle may influence individual responses to supplementation, including the bergamot flavanones naringin and naringenin, which are implicated in lipid modulation.
evidence level2
citationYu X (2026)
sourceLipid Metabolism Modulation by a Flavonoid-Standardized <i>Citrus Bergamia</i> Extract in an Asian Population: Findings From a Double-Blind, Placebo-Controlled Clinical Trial.
topicCitrus Flavanones Blood Pressure Meta-Analysis
claimThe aim of this double-blind, placebo-controlled clinical trial (RCT) is to assess the effects of the supplementation for four months of a standardised bergamot extract at the dosage of 375 mg/day, providing 150 mg/day of flavonoids, on lipid parameters of 108 East Asian adults with LDL-Cholesterol (LDL-C) 100-159 mg/day, since to date, the RCTs have been conducted on Caucasian subjects only.
evidence level2
citationYu X (2026)
sourceLipid Metabolism Modulation by a Flavonoid-Standardized <i>Citrus Bergamia</i> Extract in an Asian Population: Findings From a Double-Blind, Placebo-Controlled Clinical Trial.
topicCitrus Flavanones Blood Pressure Meta-Analysis
claimFlavanones, a subclass of flavonoids predominantly found in citrus fruits, have attracted growing interest for their potential role in cardiometabolic health.
evidence level3
citationDoaei S (2026)
sourceFlavanone Intake and Cardiometabolic Outcomes: A Synthesis of Meta-Analytic Evidence from Cohort and Clinical Studies.
topicCitrus Flavanones Blood Pressure Meta-Analysis
claimWhile evidence linking overall flavonoid intake to cardiometabolic benefits is relatively consistent, flavanones have received less attention, and available findings remain scattered across heterogeneous outcomes and study designs.
evidence level3
citationDoaei S (2026)
sourceFlavanone Intake and Cardiometabolic Outcomes: A Synthesis of Meta-Analytic Evidence from Cohort and Clinical Studies.
topicCitrus Flavanones Blood Pressure Meta-Analysis
claimThis review synthesizes meta-analytic evidence from prospective cohort and intervention studies to provide a comprehensive assessment of the relationship between flavanone intake and cardiometabolic health.
evidence level3
citationDoaei S (2026)
sourceFlavanone Intake and Cardiometabolic Outcomes: A Synthesis of Meta-Analytic Evidence from Cohort and Clinical Studies.

Source documents

  1. Lipid Metabolism Modulation by a Flavonoid-Standardized <i>Citrus Bergamia</i> Extract in an Asian Population: Findings From a Double-Blind, Placebo-Controlled Clinical Trial.
  2. Flavanone Intake and Cardiometabolic Outcomes: A Synthesis of Meta-Analytic Evidence from Cohort and Clinical Studies.